Gene Therapy Is Showing Promise As a Cancer Fighter. Aventis, Schering-Plough Launch Advanced Trials
Article Abstract:
Aventis and Schering-Plough have both launched phase 3 trials of their anti-cancer therapy, which puts cancer gene therapy further along than any other area of gene therapy research.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Trials on Humans Will Begin for Drug Based on Genes. Human Genome Sciences Extends Lead Over Rivals
Article Abstract:
Human Genome Sciences Inc. (Rockville, MD) received approval from the FDA for a drug trial of a B-lymphocyte stimulator, which has shown promise in rebuilding impaired immune systems. The test will concentrate on cancer and elderly patients.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
AIDS vaccine tests set for Africa, Asia (Rhone-Poulenc, VaxGen plan separate trials)
Article Abstract:
Two companies have announced their intention to test experimental AIDS vaccines in Africa and Thailand. France's Rhone-Poulenc has already begun testing in Uganda. California-based VaxGen Inc. has received permission from the government of Thailand to launch the largest AIDS vaccine clinical trial outside of the United States.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: NTT takes on the big boys; having triumphed at home Japan's giant steps into international ring. (Nippon Telegraph and Telephone Corp.)
- Abstracts: Salomon grabs top slot in Euro debt issuance; Newly muscular staff helps win bond battle. Making the case for growth
- Abstracts: Ocean Spray drops its lawsuit over PepsiCo's Tropicana deal. Coca-Cola find it's difficult to give up school contracts
- Abstracts: Progress at PetroChina? Public oil firm aims to strike out on its own. Zhenhai stands to gain from China's oil-sector reforms
- Abstracts: Nortel negotiates to buy Swiss plant from JDS for $3 billion in stock. Nortel Networks will acquire Xros in stock deal